# Terreno Realty Corp: financial statements, quarterly

TRNO · NYSE · CIK 1476150 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trno.md) · [Financials](/companies/trno/financials.md) · [Filings](/companies/trno/filings.md) · [Insiders](/companies/trno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [82.9](/filings/0001476150-24-000016.md) | [86.5 d](/filings/0001476150-26-000011.md) | [85.0](/filings/0001476150-25-000011.md) | [94.2](/filings/0001476150-25-000042.md) | [99.6](/filings/0001476150-25-000060.md) | [104 d](/filings/0001476150-26-000011.md) | [110](/filings/0001476150-26-000019.md) | [112](/filings/0001476150-26-000035.md) | [116](/filings/0001476150-25-000060.md) | [137 d](/filings/0001476150-26-000011.md) | [124](/filings/0001476150-26-000019.md) | [125](/filings/0001476150-26-000035.md) |
| Interest expense | $m | [5.8](/filings/0001476150-23-000014.md) | [5.7 d](/filings/0001476150-24-000004.md) | [5.2](/filings/0001476150-24-000008.md) | [5.5](/filings/0001476150-25-000042.md) | [4.9](/filings/0001476150-25-000060.md) | [5.3 d](/filings/0001476150-26-000011.md) | [7.9](/filings/0001476150-26-000019.md) | [7.0](/filings/0001476150-26-000035.md) | [8.4](/filings/0001476150-25-000060.md) | [9.5 d](/filings/0001476150-26-000011.md) | [9.0](/filings/0001476150-26-000019.md) | [8.3](/filings/0001476150-26-000035.md) |
| Net income | $m | [30.3](/filings/0001476150-24-000016.md) | [57.6 d](/filings/0001476150-26-000011.md) | [36.1](/filings/0001476150-25-000060.md) | [35.7](/filings/0001476150-25-000060.md) | [36.6](/filings/0001476150-25-000060.md) | [76.1 d](/filings/0001476150-26-000011.md) | [48.1](/filings/0001476150-26-000035.md) | [93.3](/filings/0001476150-26-000035.md) | [103](/filings/0001476150-25-000060.md) | [158 d](/filings/0001476150-26-000011.md) | [69.4](/filings/0001476150-26-000035.md) | [57.6](/filings/0001476150-26-000035.md) |
| Diluted EPS | $ per share | [0.36](/filings/0001476150-24-000016.md) | not reported | [0.40](/filings/0001476150-25-000011.md) | [0.37](/filings/0001476150-25-000042.md) | [0.37](/filings/0001476150-25-000060.md) | not reported | [0.47](/filings/0001476150-26-000019.md) | [0.90](/filings/0001476150-26-000035.md) | [1.00](/filings/0001476150-25-000060.md) | not reported | [0.66](/filings/0001476150-26-000019.md) | [0.54](/filings/0001476150-26-000035.md) |
| Basic EPS | $ per share | [0.36](/filings/0001476150-24-000016.md) | not reported | [0.40](/filings/0001476150-25-000011.md) | [0.37](/filings/0001476150-25-000042.md) | [0.37](/filings/0001476150-25-000060.md) | not reported | [0.48](/filings/0001476150-26-000019.md) | [0.90](/filings/0001476150-26-000035.md) | [1.00](/filings/0001476150-25-000060.md) | not reported | [0.66](/filings/0001476150-26-000019.md) | [0.54](/filings/0001476150-26-000035.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [96.2](/filings/0001476150-24-000016.md) | [165](/filings/0001476150-26-000011.md) | [650](/filings/0001476150-25-000011.md) | [182](/filings/0001476150-25-000042.md) | [244](/filings/0001476150-25-000060.md) | [18.1](/filings/0001476150-26-000035.md) | [157](/filings/0001476150-26-000019.md) | [128](/filings/0001476150-26-000035.md) | [26.2](/filings/0001476150-25-000060.md) | [25.0](/filings/0001476150-26-000035.md) | [87.9](/filings/0001476150-26-000019.md) | [51.2](/filings/0001476150-26-000035.md) |
| Total assets | $m | [3,739](/filings/0001476150-23-000014.md) | [3,905](/filings/0001476150-25-000004.md) | [4,439](/filings/0001476150-24-000008.md) | [4,467](/filings/0001476150-24-000012.md) | [4,571](/filings/0001476150-24-000016.md) | [4,770](/filings/0001476150-26-000011.md) | [4,907](/filings/0001476150-25-000011.md) | [4,982](/filings/0001476150-25-000042.md) | [5,329](/filings/0001476150-25-000060.md) | [5,388](/filings/0001476150-26-000035.md) | [5,552](/filings/0001476150-26-000019.md) | [5,712](/filings/0001476150-26-000035.md) |
| Total liabilities | $m | [1,002](/filings/0001476150-23-000014.md) | [990](/filings/0001476150-25-000004.md) | [994](/filings/0001476150-24-000008.md) | [1,026](/filings/0001476150-24-000012.md) | [940](/filings/0001476150-24-000016.md) | [1,108](/filings/0001476150-26-000011.md) | [1,011](/filings/0001476150-25-000011.md) | [1,039](/filings/0001476150-25-000042.md) | [1,334](/filings/0001476150-25-000060.md) | [1,242](/filings/0001476150-26-000035.md) | [1,256](/filings/0001476150-26-000019.md) | [1,280](/filings/0001476150-26-000035.md) |
| Long-term debt | $m | [771](/filings/0001476150-23-000014.md) | [772](/filings/0001476150-25-000004.md) | [772](/filings/0001476150-24-000008.md) | [772](/filings/0001476150-24-000012.md) | [672](/filings/0001476150-24-000016.md) | [823](/filings/0001476150-26-000011.md) | [742](/filings/0001476150-25-000011.md) | [742](/filings/0001476150-25-000042.md) | [1,023](/filings/0001476150-25-000060.md) | [943](/filings/0001476150-26-000035.md) | [942](/filings/0001476150-26-000019.md) | [942](/filings/0001476150-26-000035.md) |
| Shareholders' equity | $m | [2,737](/filings/0001476150-24-000016.md) | [2,915](/filings/0001476150-26-000011.md) | [3,445](/filings/0001476150-25-000060.md) | [3,441](/filings/0001476150-25-000060.md) | [3,631](/filings/0001476150-25-000060.md) | [3,662](/filings/0001476150-26-000035.md) | [3,896](/filings/0001476150-26-000035.md) | [3,943](/filings/0001476150-26-000035.md) | [3,996](/filings/0001476150-25-000060.md) | [4,146](/filings/0001476150-26-000035.md) | [4,296](/filings/0001476150-26-000035.md) | [4,432](/filings/0001476150-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [53.3 d](/filings/0001476150-24-000016.md) | [39.1 d](/filings/0001476150-26-000011.md) | [47.0](/filings/0001476150-25-000011.md) | [64.3 d](/filings/0001476150-25-000042.md) | [70.0 d](/filings/0001476150-25-000060.md) | [51.3 d](/filings/0001476150-26-000011.md) | [61.4](/filings/0001476150-26-000019.md) | [60.6 d](/filings/0001476150-26-000035.md) | [79.5 d](/filings/0001476150-25-000060.md) | [70.3 d](/filings/0001476150-26-000011.md) | [61.9](/filings/0001476150-26-000019.md) | [74.9 d](/filings/0001476150-26-000035.md) |
| Dividends paid | $m | [33.5 d](/filings/0001476150-24-000016.md) | [38.4 d](/filings/0001476150-26-000011.md) | [39.1](/filings/0001476150-25-000011.md) | [43.5 d](/filings/0001476150-25-000042.md) | [43.5 d](/filings/0001476150-25-000060.md) | [48.9 d](/filings/0001476150-26-000011.md) | [48.9](/filings/0001476150-26-000019.md) | [50.6 d](/filings/0001476150-26-000035.md) | [50.6 d](/filings/0001476150-25-000060.md) | [53.8 d](/filings/0001476150-26-000011.md) | [54.1](/filings/0001476150-26-000019.md) | [55.3 d](/filings/0001476150-26-000035.md) |
| Share repurchases | $m | [0.8 d](/filings/0001476150-24-000016.md) | [0.0 d](/filings/0001476150-26-000011.md) | [1.0](/filings/0001476150-25-000011.md) | [0.1 d](/filings/0001476150-25-000042.md) | [2.3 d](/filings/0001476150-25-000060.md) | [0.0 d](/filings/0001476150-26-000011.md) | [1.9](/filings/0001476150-26-000019.md) | [0.1 d](/filings/0001476150-26-000035.md) | [1.3 d](/filings/0001476150-25-000060.md) | [0.0 d](/filings/0001476150-26-000011.md) | [2.3](/filings/0001476150-26-000019.md) | [0.0 d](/filings/0001476150-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.6](/filings/0001476150-23-000014.md) | [80.3](/filings/0001476150-24-000008.md) | [83.1](/filings/0001476150-24-000012.md) | [84.3](/filings/0001476150-24-000016.md) | [89.4](/filings/0001476150-25-000011.md) | [96.4](/filings/0001476150-25-000042.md) | [97.9](/filings/0001476150-25-000060.md) | [101](/filings/0001476150-26-000019.md) | [103](/filings/0001476150-26-000035.md) | [103](/filings/0001476150-25-000060.md) | [105](/filings/0001476150-26-000019.md) | [107](/filings/0001476150-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 108,970,310 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001476150-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.